Medicago Vaccine

• Governments seek buyer as Quebec COVID-19 vaccine manufacturer Medicago set to close

  Pierre Fitzgibbon said the province has had preliminary talks with potential buyers in the pharmaceutical sector to keep Medicago's expertise and skilled workforce in Quebec.

  Canada

  Feb 3, 2023
  
• Medicago to cease operations in Quebec, scuttling COVID-19 vaccine production plans

  Medicago has shut down its COVID-19 vaccine project in Quebec after its sole shareholder decided to no longer invest in the company, the company announced Thursday.

  Health

  Feb 2, 2023
  
• Advertisement
• Feds won’t buy tobacco company’s stake in Medicago to free up COVID vaccines: minister

  Innovation, Science and Industry Minister Francois-Philippe Champagne said the government is "working on a solution" after the WHO rejected the vaccine because of its tobacco ties.

  Health

  Jul 7, 2022
• Advertisement
• WHO rejects Medicago’s COVID-19 vaccine due to ties to tobacco giant

  The first Canadian-made COVID-19 vaccine by Medicago has been rejected by the World Health Organization (WHO) due to its ties to a major tobacco company.

  Canada

  Mar 25, 2022
• Medicago’s Canada-made COVID-19 vaccine faces WHO rejection due to tobacco industry ties

  Dr. Mariângela Simão, WHO's assistant director-general for access to medicines and health products, spoke about the vaccine during a press briefing Wednesday.

  Health

  Mar 17, 2022
• Medicago’s Canada-made COVID-19 vaccine approved by Health Canada

  The first Canadian COVID-19 vaccine was approved for use Thursday.

  Health

  Feb 24, 2022
• Medicago clinical trial participants want equal access to Quebec COVID-19 vaccine passport

  On Tuesday, health officials, including the province's director of public health, Dr. Horacio Arruda, indicated they may cut the participants some slack.

  Health

  Aug 26, 2021
• Canada’s Medicago says its COVID-19 vaccine shows promising antibody results in trial

  Medicago said a Phase 2 clinical trial involving hundreds of participants found the vaccine appears to produce 10 times the antibodies as are seen in people who have had COVID-19.

  Health

  May 18, 2021
• Advertisement
• Canada’s Medicago begins late-stage study of COVID-19 vaccine with GlaxoSmithKline

  Medicago, which has Canada's most advanced COVID-19 vaccine project under development, expects to report results from a mid-stage trial of the vaccine in April.

  Canada

  Mar 16, 2021
• Advertisement
• Canadian company sees positive results in early coronavirus vaccine tests

  Medicago says the side effects were generally mild to moderate and short in duration.

  Canada

  Nov 10, 2020